Obesity and cardiovascular disease: an ESC clinical consensus statement

被引:32
作者
Koskinas, Konstantinos C. [1 ]
Van Craenenbroeck, Emeline M. [2 ,3 ]
Antoniades, Charalambos [4 ]
Blueher, Matthias [5 ,6 ]
Gorter, Thomas M. [7 ]
Hanssen, Henner [8 ]
Marx, Nikolaus [9 ]
McDonagh, Theresa A. [10 ,11 ]
Mingrone, Geltrude [12 ,13 ,14 ]
Rosengren, Annika [15 ,16 ]
Prescott, Eva B. [17 ]
机构
[1] Univ Bern, Bern Univ Hosp INSELSPITAL, Dept Cardiol, Freiburgstr 18, CH-3010 Bern, Switzerland
[2] Antwerp Univ Hosp, Dept Cardiol, Drie Eikenstr 655, B-2650 Antwerp, Belgium
[3] Univ Antwerp, Res Grp Cardiovasc Dis, GENCOR, Antwerp, Belgium
[4] Univ Oxford, Radcliffe Dept Med, Acute Multidisciplinary Imaging & Intervent Ctr, Oxford, England
[5] Univ Leipzig, Helmholtz Zentrum Munchen, Leipzig, Germany
[6] Univ Hosp Leipzig, Leipzig, Germany
[7] Univ Med Ctr Groningen, Dept Cardiol, Groningen, Netherlands
[8] Univ Basel, Dept Sport Exercise & Hlth, Basel, Switzerland
[9] Rhein Westfal TH Aachen, Dept Internal Med Cardiol 1, Aachen, Germany
[10] Kings Coll Hosp London, Cardiol Dept, London, England
[11] Kings Coll London, London, England
[12] Kings Coll London, Sch Cardiovasc & Metab Med & Sci, London, England
[13] Fdn Policlin Univ A Gemelli, Dept Med & Surg Sci, Rome, Italy
[14] Catholic Univ, Rome, Italy
[15] Univ Gothenburg, Inst Med, Dept Mol & Clin Med, Gothenburg, Sweden
[16] Sahlgrens Univ Hosp, Vastra Gotaland Reg, Gothenburg, Sweden
[17] Univ Copenhagen, Bispebjerg Frederiksberg Hosp, Bispebjerg Bakke 23, DK-2400 Copenhagen, Denmark
关键词
Anti-obesity drugs; Adipose tissue; Arrhythmia; Atherosclerosis; Bariatric interventions; Cardiovascular disease; Lifestyle interventions; Heart failure; Cardiovascular risk factors; Venous Thromboembolism; Valvular heart disease; BODY-MASS INDEX; EPICARDIAL ADIPOSE-TISSUE; LIFE-STYLE INTERVENTION; PERCUTANEOUS CORONARY INTERVENTION; ALL-CAUSE MORTALITY; INDUCED WEIGHT-LOSS; DOSE-RESPONSE METAANALYSIS; REDUCED EJECTION FRACTION; OBSTRUCTIVE SLEEP-APNEA; SUDDEN CARDIAC DEATH;
D O I
10.1093/eurheartj/ehae508
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The global prevalence of obesity has more than doubled over the past four decades, currently affecting more than a billion individuals. Beyond its recognition as a high-risk condition that is causally linked to many chronic illnesses, obesity has been declared a disease per se that results in impaired quality of life and reduced life expectancy. Notably, two-thirds of obesity-related excess mortality is attributable to cardiovascular disease. Despite the increasingly appreciated link between obesity and a broad range of cardiovascular disease manifestations including atherosclerotic disease, heart failure, thromboembolic disease, arrhythmias, and sudden cardiac death, obesity has been underrecognized and sub-optimally addressed compared with other modifiable cardiovascular risk factors. In the view of major repercussions of the obesity epidemic on public health, attention has focused on population-based and personalized approaches to prevent excess weight gain and maintain a healthy body weight from early childhood and throughout adult life, as well as on comprehensive weight loss interventions for persons with established obesity. This clinical consensus statement by the European Society of Cardiology discusses current evidence on the epidemiology and aetiology of obesity; the interplay between obesity, cardiovascular risk factors and cardiac conditions; the clinical management of patients with cardiac disease and obesity; and weight loss strategies including lifestyle changes, interventional procedures, and anti-obesity medications with particular focus on their impact on cardiometabolic risk and cardiac outcomes. The document aims to raise awareness on obesity as a major risk factor and provide guidance for implementing evidence-based practices for its prevention and optimal management within the context of primary and secondary cardiovascular disease prevention. Graphical Abstract Main causal factors and cardiovascular consequences of obesity. CV, cardiovascular; HFpEF, heart failure with preserved ejection fraction; HFrEF, heart failure with reduced ejection fraction; SCD, sudden cardiac death.
引用
收藏
页码:4063 / 4098
页数:36
相关论文
共 50 条
  • [21] Heart failure diagnosis in the general community - who, how and when? A clinical consensus statement of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)
    Docherty, Kieran F.
    Lam, Carolyn S. P.
    Rakisheva, Amina
    Coats, Andrew J. S.
    Greenhalgh, Trisha
    Metra, Marco
    Petrie, Mark C.
    Rosano, Giuseppe M. C.
    EUROPEAN JOURNAL OF HEART FAILURE, 2023, : 1185 - 1198
  • [22] Impact of Obesity on Cardiovascular Disease
    Zalesin, Kerstyn C.
    Franklin, Barry A.
    Miller, Wendy M.
    Peterson, Eric D.
    McCullough, Peter A.
    MEDICAL CLINICS OF NORTH AMERICA, 2011, 95 (05) : 919 - +
  • [23] Renal denervation in the management of hypertension in adults. A clinical consensus statement of the ESC Council on Hypertension and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)
    Barbato, Emanuele
    Azizi, Michel
    Schmieder, Roland E.
    Lauder, Lucas
    Boehm, Michael
    Brouwers, Sofie
    Bruno, Rosa Maria
    Dudek, Dariusz
    Kahan, Thomas
    Kandzari, David E.
    Luscher, Thomas F.
    Parati, Gianfranco
    Pathak, Atul
    Ribichini, Flavio L.
    Schlaich, Markus P.
    Sharp, Andrew S. P.
    Sudano, Isabella
    Volpe, Massimo
    Tsioufis, Costas
    Wijns, William
    Mahfoud, Felix
    EUROPEAN HEART JOURNAL, 2023, 44 (15) : 1313 - 1330
  • [24] The Science of Obesity Management: An Endocrine Society Scientific Statement
    Bray, George A.
    Heisel, William E.
    Afshin, Ashkan
    Jensen, Michael D.
    Dietz, William H.
    Long, Michael
    Kushner, Robert F.
    Daniels, Stephen R.
    Wadden, Thomas A.
    Tsai, Adam G.
    Hu, Frank B.
    Jakicic, John M.
    Ryan, Donna H.
    Wolfe, Bruce M.
    Inge, Thomas H.
    ENDOCRINE REVIEWS, 2018, 39 (02) : 79 - 132
  • [25] Obesity and cardiovascular disease: From pathophysiology to risk stratification
    Marinou, Kyriakoula
    Tousoulis, Dimitris
    Antonopoulos, Alexios S.
    Stefanadi, Elli
    Stefanadis, Christodoulos
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2010, 138 (01) : 3 - 8
  • [26] Diabetic myocardial disorder. A clinical consensus statement of the Heart Failure Association of the ESC and the ESC Working Group on Myocardial & Pericardial Diseases
    Seferovic, Petar M.
    Paulus, Walter J.
    Rosano, Giuseppe
    Polovina, Marija
    Petrie, Mark C.
    Jhund, Pardeep S.
    Tschoepe, Carsten
    Sattar, Naveed
    Piepoli, Massimo
    Papp, Zoltan
    Standl, Eberhard
    Mamas, Mamas A.
    Valensi, Paul
    Linhart, Ales
    Lalic, Nebojsa
    Ceriello, Antonio
    Doehner, Wolfram
    Ristic, Arsen
    Milinkovic, Ivan
    Seferovic, Jelena
    Cosentino, Francesco
    Metra, Marco
    Coats, Andrew J. S.
    EUROPEAN JOURNAL OF HEART FAILURE, 2024, 26 (09) : 1893 - 1903
  • [27] American Association of Clinical Endocrinology Consensus Statement: Addressing Stigma and Bias in the Diagnosis and Management of Patients with Obesity/Adiposity-Based Chronic Disease and Assessing Bias and Stigmatization as Determinants of Disease Severity
    Nadolsky, Karl
    Addison, Brandi
    Agarwal, Monica
    Almandoz, Jaime P.
    Bird, Melanie D.
    Chaplin, Michelle DeGeeter
    Garvey, W. Timothy
    Kyle, Theodore K.
    ENDOCRINE PRACTICE, 2023, 29 (06) : 417 - 427
  • [28] Obesity phenotypes and cardiovascular risk: From pathophysiology to clinical management
    Preda, Alberto
    Carbone, Federico
    Tirandi, Amedeo
    Montecucco, Fabrizio
    Liberale, Luca
    REVIEWS IN ENDOCRINE & METABOLIC DISORDERS, 2023, 24 (05) : 901 - 919
  • [29] Obesity and cardiovascular disease: friend or foe?
    Kim, Seong Hwan
    Despres, Jean-Pierre
    Koh, Kwang Kon
    EUROPEAN HEART JOURNAL, 2016, 37 (48) : 3560 - 3568B
  • [30] Childhood Obesity and Cardiovascular Disease Risk
    Chung, Stephanie T.
    Krenek, Andrea
    Magge, Sheela N.
    CURRENT ATHEROSCLEROSIS REPORTS, 2023, 25 (07) : 405 - 415